Published: March 27, 2020

FOIA to FDA Seeking Records Sufficient to Identify Date Gilead Submitted Orphan Drug Designation Request for COVID-19 Treatment

FOIA to the Food and Drug Administration (FDA) seeking records sufficient to identify the date Gilead submitted its request for orphan-drug designation for remdesivir as a treatment for COVID-19. HHS-FDA-20-0718

Part of Investigation:

Select a tag below to see a full list of related documents

Topic
Areas of Investigation
Jurisdiction
Entity
Status
Open
FOIA ID #
Download